Active ingredientIrsogladineCat. No. P-I077-001CAS 57381-26-7Family · Pharmaceutical analytical standards
Irsogladine
A gastric mucosal protective agent developed in Japan in the 1970s and 1980s for peptic ulcer disease and acute gastritis: rather than reducing acid secretion, it strengthens the mucosal defences. This family brings together the active ingredient and other impurities.
Did you know?It raises cyclic AMP in cells and facilitates communication through gap junctions, the tiny channels that link neighbouring cells to one another.
Go to the active ingredient →Active ingredientIrsogladineCat. No. P-I077-001CAS 57381-26-7
ImpurityIrsogladine Impurity 1Cat. No. P-I077-002CAS 30222-00-5
ImpurityIrsogladine Impurity 2Cat. No. P-I077-003CAS 61382-84-1
ImpurityIrsogladine Impurity 3Cat. No. P-I077-004CAS 29366-77-6
ImpurityIrsogladine Impurity 4Cat. No. P-I077-005CAS 4514-54-9
ImpurityIrsogladine Impurity 5Cat. No. P-I077-006
ImpurityIrsogladine Impurity 6Cat. No. P-I077-007
ImpurityIrsogladine Impurity 7Cat. No. P-I077-008
ImpurityIrsogladine-N-OxideCat. No. P-I077-009CAS 104766-03-2No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.